Factors Influencing Pediatric Asthma



Status:Completed
Conditions:Asthma
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:6 - 17
Updated:10/7/2017
Start Date:March 14, 2013
End Date:May 25, 2017

Use our guide to learn which trials are right for you!

Asthma is a chronic lung disease with serious morbidity and potential mortality. Multiple
physiologic, environmental and social conditions impact the prevalence and severity of
asthma. Even when diagnosed, effective control can be impeded by improper use of medication,
not understanding or being unable to avoid environmental triggers, lack of continuity in
follow-up care, and lack of an asthma action plan. American Indians are especially at-risk
for health problems related to asthma. American Indians have the highest asthma rate among
single-race groups; 18.5% of American Indians are diagnosed with asthma, while only 11% are
diagnosed with asthma in the general population but little is known about why this is true.
Asthma is a prototypic example of the interaction of biologic, environmental and psychosocial
influences on disease and this study investigated the possible improvement in asthma control
from an intensive educational intervention.

The primary aim of this study was to test the hypothesis that intensive patient education
regarding self-directed, stepped care will result in reduced morbidity and medical care
utilization, while increasing quality of life.

One half (54) of the identified cases will be randomized to receive the previously
established "BREATHE" study educational program, emphasizing patient-centered, self
management of asthma. Periodic follow-up through personal contact and surveillance of IHS
RPMS or other medical provider records was conducted.

Inclusion Criteria:

- Cases must be "American Indian" (eligibile for care within the Indian Health Service);
and at least 2 of the following 3 criteria:

1. a diagnosis of asthma on at least 2 occasions by more than one provider during
the past 2 years.

2. refills of asthma treatment medications on at least 2 occasions during the past 2
years.

3. Improvement of spirometry FEV1 of 20% with use of albuterol MDI or nebulizer.

- Controls meet the same demographic criteria as cases, but must also meet all of the
following criteria.

1. No diagnosis of asthma by any provider during the past 2 years.

2. No prescriptions of any asthma meds during the past 2 years.

3. FEV1 on spirometry greater than 80% of predicted value Exclusion Criteria:

Exclusion Criteria:

1. Birthweight less than 2500 grams

2. Neonatal ventilator treatment

3. Hospitalization at birth greater than 15 days.

4. Congenital heart anomaly requiring surgery

5. Diagnosis of cystic fibrosis

6. Congenital lung, diaphragm, chest wall, or airway anomaly

7. Diagnosis of pneumonia, pertussis, or tuberculosis within the past year

8. Congenital muscular disorder
We found this trial at
1
site
Eagle Butte, South Dakota 57625
?
mi
from
Eagle Butte, SD
Click here to add this to my saved trials